Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. For more information, go to www.bayer.com.
Recon Strategy is a healthcare and life sciences focused consulting firm founded in 2010 by alumni of the Boston Consulting Group. Senior partners work directly with executives and board members at biotech, diagnostics, medical device, payer, and health system clients on a broad set of topics including R&D, commercial, and business strategy.
Cell & Gene provides actionable information to professionals involved in the development and commercialization of cell and gene therapies. Through the original editorial published on the site, Cell & Gene facilitates the sharing of insights on challenges, trends, and best practices in this burgeoning field. Cell & Gene’s editorial scope spans the entire product lifecycle from basic research to commercialization.
Sponsors of the World Medical Innovation Forum comprise a select group of industry leading organizations committed to innovation and its ability to improve care. Joining the Forum Community signals your active involvement in the premier venue for academic and corporate collaboration.
Sponsorship brings visibility and insight to strategic decision-making on the most important industry and cross-industry related issues, and high levels of brand visibility in an environment ideally suited to engaging with the most senior leaders in global healthcare and medical innovation.
If you wish to join the World Forum community, please contact:
Michelle Grdina, Senior Project Manager, World Medical Innovation Forum, for further details: firstname.lastname@example.org